Shareholding disclosure

Christian Zahnd

Declared position

4.07%

Threshold

Crossed upwards

Timeline

Published

19.07.2016

Transaction

17.07.2016

Voting rights breakdown

Voting rights acquired4.07%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAG7I000L3

Beneficial owner

Christian Zahnd

Declared address

Christian Zahnd, Zürich

End of lock-up group following share placement

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Christian Zahnd

Molecular Partners AG19.07.2016TAG7I000L3

Disclosure summary

Christian Zahnd disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 19.07.2016, at 4.07% of voting rights. Notice category: Single shareholder.

Disclosed position

4.07%

Voting rights acquired

Voting rights acquired4.07%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Christian Zahnd disclosed a holding in Molecular Partners AG, published on 19.07.2016.

Publication date19.07.2016

Transaction date17.07.2016

Issuing companyMolecular Partners AG

Beneficial ownerChristian Zahnd

Declared addressChristian Zahnd, Zürich

CategorySingle shareholder

Voting rights acquired4.07%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAG7I000L3

Conditions

End of lock-up group following share placement

Source: SIX Exchange Regulation · Publication date: 19.07.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open